Stage- and tissue-specific effect of cyclophosphamide during tooth development.

Area of Science:

• Developmental biology
• Toxicology
• Dental research

Background:

• Cyclophosphamide (CPA) is a widely used chemotherapy agent with known teratogenic effects.
• Understanding CPA's impact on tooth development is crucial for managing treatment side effects in young patients.

Purpose of the Study:

• To investigate the toxic effects of cyclophosphamide (CPA) on the development of rodent molars.
• To determine the relationship between the timing of CPA administration and the resulting dental defects.

Main Methods:

• Postnatal mice were administered CPA intraperitoneally between Day 1 and Day 10.
• Morphological evaluation at Day 26 included micro-computed tomography and histological analysis.
• Cell proliferation and apoptosis assays were performed to assess cellular responses.

Main Results:

• CPA administration at critical developmental stages led to tooth agenesis or severe hypoplasia.
• Early exposure (Day 2, bud stage) caused crown and root hypoplasia, affecting cusp and root formation.
• Later exposure (Day 6, cap/early bell stage) resulted in M3 agenesis/hypoplasia and reduced cell proliferation.
• Late bell stage exposure (Day 10) primarily affected root shortening without impacting crown morphogenesis.

Conclusions:

• The timing of CPA administration significantly influences the type and severity of dental defects.
• The cap/early bell stage is the most vulnerable period for CPA-induced tooth agenesis.
• CPA exposure impacts both crown and root development, with stage-specific susceptibility.